Fig. 1From: Effects of dapagliflozin in the progression of atherosclerosis in patients with type 2 diabetes: a meta-analysis of randomized controlled trialsThe flowchart of the selection process. In total, twelve studies articles met the eligibility criteria and were included in the meta-analysisBack to article page